Ronit Juthani

Prognostic utility of neutrophil:lymphocyte ratio (NLR) in patients receiving 177Lu-PSMA-617 (LuPSMA) for metastatic castration resistant prostate cancer (mCRPC).

Ronit Juthani, Caiwei Zhong, W. Xie, Hailey Stoltenberg et autres

207 Background: LuPSMA has a proven clinical benefit in mCRPC, but there is a need to develop predictive and prognostic biomarkers of response. Neutrophil:lymphocyte ratio (NLR) has shown prognostic value across a range of therapies for solid tumors, but there is limited …

us (code pays fourni par la source)

Representation of older adults in registrational trials associated with therapeutic approvals in follicular lymphoma

Ronit Juthani, Kelly Pugh, Nina Rosa Neuendorff, Pallawi Torka

Abstract Introduction: Follicular lymphoma (FL) is a disease of older adults (age≥65 years, yrs) (OA) with a median age at diagnosis of 64 yrs, and around 50% patients (pts) diagnosed over the age of 65 yrs and 20% pts over the age …

us, de (code pays fourni par la source)

Reporting of older subgroups in registration trials of FDA and EMA approvals between 2017 and 2023 for diffuse large B-cell lymphoma: A systematic review

Ronit Juthani, Kelly Pugh, Colm Mac Eochagáin, Céline Soudant et autres

Abstract Introduction: Diffuse large B-cell lymphoma (DLBCL) is primarily a disease of older adults (OA). The median age at diagnosis is in the mid-sixties, and 55% of patients (pts) are >=65 years (yrs) at time of diagnosis. The United States Food and …

us, ie, de (code pays fourni par la source)

1062 Understanding educational needs and barriers in immune-related adverse event management: an ASPIRE initiative

Vera Kazakova, Ronit Juthani, Kerry L. Reynolds, Eric Roeland et autres

Background With expanding use of immune checkpoint inhibitors, the incidence of immune-related adverse events (irAE) is on the rise. 1 The Alliance for Support and Prevention of irAEs (ASPIRE) conducted a needs assessment survey to evaluate educational preferences and barriers to effective …

us (code pays fourni par la source)

Exploring trends in Medicare utilization and reimbursement of germline genetic testing for cancer from 2017-2022.

Yagnapriya Ammakola, Ronit Juthani, Atulya Aman Khosla, Kala Seetharaman et autres

5 Background: Germline genetic testing is recommended in NCCN and ASCO guidelines to enable personalized treatment and assess hereditary cancer risk. Studies have found a significant prevalence of actionable germline mutations in the elderly population. Germline testing in the elderly is underutilized …

us (code pays fourni par la source)

722eTiP Interim analysis of a phase II study of BPM31510 (a lipid nanodispersion of oxidized CoQ10) with vitamin K in combination with Standard of care (SOC) RT and TMZ in glioblastoma multiforme (GBM) patients without prior therapy

Brian Stockdale, Seema Nagpal, Adam D. Cohen, Chirag G. Patil et autres

us (code pays fourni par la source)

Representation of older adults in registrational trials associated with therapeutic approvals in diffuse large B-cell lymphoma

Ronit Juthani, Kelly Pugh, Nina Rosa Neuendorff, Pallawi Torka

Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma (NHL) subtype, accounting for 30–40 % of all NHL cases globally [1]. DLBCL is predominantly a disease of older adults with a median age at diagnosis of 67 years. About a …

us, de (code pays fourni par la source)

Corrigendum to “Representation of older adults in registrational trials associated with therapeutic approvals in diffuse large B-cell lymphoma” [Journal of Geriatric Oncology 16(6) (2025) 102264]

Ronit Juthani, Kelly Pugh, Nina Rosa Neuendorff, Pallawi Torka

us, de (code pays fourni par la source)

Abstract P3-05-05: A Comprehensive Study of Breast Cancer Mortality and DALY Trends considering Smoking as a Risk Factor from 1991-2021 in the USA and exploring the State-level disparities

Vaibhavi Mukhtiar, Charmi Bhanushali, Ronit Juthani, Raj C. Shah et autres

Abstract Introduction: Breast cancer is the second leading cause of cancer death in women. Smoking has been considered an important risk factor. Over the past 25 years, intensive screening strategies have been implemented to detect breast cancer early. Numerous legislative acts have …

Kidney disease related mortality: Trends and disparities among patients with multiple myeloma.

Bolivia Fernandes, Warren Fernandes, Vedant Shah, Mansi Mehta et autres

e19562 Background: Kidney disease is a common and severe comorbidity among patients with multiple myeloma, significantly impacting outcomes and mortality. Disparities in kidney disease-related mortality across demographic, geographic, and socioeconomic factors remain underexplored. Methods: We analyzed CDC Wide-Ranging Online Data (1999–2020) to …

us (code pays fourni par la source)

Difference in survival outcomes between de novo vs therapy-related neuroendocrine cancer of prostate (NCP): A SEER-based analysis.

Ronit Juthani, Kala Seetharaman, Kriti Mittal

e17167 Background: Neuroendocrine cancer of prostate (NCP) is an aggressive histological subtype of prostate cancer with poor prognosis and lack of effective therapeutic agents. These can either arise de novo or secondary to hormonal therapies of prostate adenocarcinoma due to lineage plasticity. …

us (code pays fourni par la source)

International medical graduates (IMGs) in leadership roles within academic oncology in the United States (US).

Shipra Gandhi, Jayasree Krishnan, Tarrant McPherson, Maria Hafez et autres

9004 Background: Although IMGs comprise one-third of US oncologists, their leadership presence at academic centers with affiliated oncology fellowship training programs has not been studied. Methods: Using Electronic Residency Application Services website for training programs, and publicly available information on corresponding institutional …

us, pk (code pays fourni par la source)